Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America

Inbunden, Engelska, 2021

AvLinda Liau,UCLA) Liau, Linda, MD, PhD, MBA (Chair, Professor, and Director of the Brain Tumor Program, Department of Neurosurgery

1 729 kr

Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

This issue of Neurosurgery Clinics, guest edited by Dr. Linda M. Liau, is dedicated to Glioblastoma: Molecular and Clinical Trials. This issue is one of four selected each year by the series consulting editors, Drs. Russell R. Lonser and Daniel K. Resnick. Topics will include-but are not limited to-Pathology & Molecular Markers, Cellular States & Genetic Diversity in Glioblastoma, Mismatch Repair in Glioblastoma Resistance, Genetic Susceptibility in Brain Cancer, Pediatric Gliomas: Molecular Landscape & Emerging Targets, Molecularly Targeted Clinical Trials, Novel Radiation Sensitizers, Immunotherapy Checkpoint Inhibitors, Brain Tumor Vaccines, CAR T Cells, Oncolytic Virotherapy, Targeting Cancer Stem Cells, Therapeutic Delivery to CNS, Theranostics: Dual Modality PET Tracers, and Neuroimaging & Novel Response Assessments.

Produktinformation

Utgivningsdatum2021-04-19
Mått178 x 254 x 15 mm
Vikt570 g
FormatInbunden
SpråkEngelska
SerieThe Clinics: Surgery
Antal sidor240
FörlagElsevier Health Sciences
ISBN9780323813051

Tillhör följande kategorier

Neurokirurgi inom Medicin

Dr. Linda Liau is Chair, Professor, and Director of the Brain Tumor Program for the Department of Neurosurgery at UCLA. She has an NIH-funded laboratory with a busy surgical practice involving intraoperative functional brain mapping for resection of brain tumors. She is the former Editor-in-Chief of the Journal of Neuro-Oncology and is the director of the UCLA Brain Cancer SPORE (Specialized Program of Research Excellence). She is an elected member of the National Academy of Medicine and has led phase 3 clinical trials for dendritic cell vaccination strategies in patients with glioblastoma.